Research on the influence of marketing authorization holder system on pharmaceutical industry innovation
HE Feng
WAN Pai-jie
PI Zhi-peng
AN Shu-han
WU Rengaowa
Abstract：Based on the quasi-natural experiment of marketing authorization holder(MAH)system pilot in 2016,this article employs the provincial panel data of the pharmaceutical manufacturing industry from 2011 to 2021 to construct a difference-in-difference model for analysis.The results show that,no matter from the perspective of innovation input or innovation output,the implementation of MAH system can significantly promote the innovation and development of China's pharmaceutical industry.The conclusion is still valid after a series of robustness tests.Mechanism analysis reveals that the pilot policy of MAH system can achieve the promotion effect on the pharmaceutical innovation by improving the agglomeration of the factors and strengthening the government support.Further research shows that the MAH pilot has a stronger incentive effect on the pharmaceutical innovation in the regions with high protection level of intellectual property.Based on these,government should focus on optimizing the policy environment of the MAH system,give full play to the advantages of factor agglomeration,increase policy guidance and government support,and continuously optimize the allocation of resources in the pharmaceutical industry,so as to promote the innovation and development of China's pharmaceutical industry.
Keywords：marketing authorization holder systempharmaceutical innovationpharmaceutical manufacturing industryfactor agglomerationgovernment support
Publication Date：2024-10-15
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：8( 1990-1997 )